Market Overview

Analyst Still Sees Nearly 100% Upside In Helios And Matheson, Says MoviePass Will Help Revive Movie Ticket Sales

Share:
Analyst Still Sees Nearly 100% Upside In Helios And Matheson, Says MoviePass Will Help Revive Movie Ticket Sales
Related HMNY
One Year Later: The Rise And Fall Of Helios And Matheson
The Week Ahead: Q3 Earnings Season, Canada Decriminalizes Cannabis
New York State AG probes MoviePass owner (Seeking Alpha)

Helios and Matheson Analytics Inc (NASDAQ: HMNY) closed up 47 percent Monday on news of an increased stake in MoviePass.

That brings the stock up 330 percent year-to-date — and one expert thinks it’s still has room to run.

“We argue large movie theater chains will benefit from MoviePass that we expect will help revive movie ticket sales, which leads to more concession sales,” Maxim analyst Brian Kinstlinger wrote in a Monday note. “Furthermore, we believe the Hollywood studios may be less hesitant than the theater chains to compensate MoviePass if it can fill more seats.”

MoviePass recently reported that it saw a 30-fold increase in paying monthly subscribers from 20,000 in August to 600,000 in October.

The Stock Story

Helios and Matheson’s initial interest in MoviePass inspired a rally of more than 1,000 percent, but the stock waned from a mid-October all-time high of $38.86 following a short report by Citron Research. The seller covered its position the following day, when investors began closing their positions.

Maxim is the only Wall Street firm covering Helios and Matheson, according to TipRanks. Forecasting rapid subscriber growth and considering lower financing risk, Kinstlinger reiterated his Buy rating on the stock and increased his price target from $20 to $25.

At the session’s close, shares were valued at $14.20.

Related Links:

How Does Helios And Matheson Make Money From MoviePass?

Helios & Matheson Ups Stake In MoviePass Again

Latest Ratings for HMNY

DateFirmActionFromTo
Sep 2018Canaccord GenuityTerminatesBuyNot Rated
Jul 2018Maxim GroupAssumesHold
Apr 2018Canaccord GenuityMaintainsBuyBuy

View More Analyst Ratings for HMNY
View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Short Sellers Price Target Reiteration Top Stories Analyst Ratings Trading Ideas Best of Benzinga

 

Related Articles (HMNY)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
AAPLWedbushInitiates Coverage On310.0
DHTJP MorganUpgrades0.0
DISBarclaysUpgrades130.0
DXCMGoldman SachsUpgrades125.0
ORLYJP MorganUpgrades398.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Earnings Scheduled For November 7, 2017

The Companies That Manipulated The Tax System, According To The Paradise Papers